Squarepoint Ops LLC Age X Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

  • $96.1 Billion
  • Q3 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$1.25 - $1.82 $24,357 - $35,464
-19,486 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$1.96 - $3.38 $38,192 - $65,862
19,486 New
19,486 $38,000

About AgeX Therapeutics, Inc.

AGE Quotes by TradingView
  • Ticker AGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,945,100
  • Description
  • AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...
More about AGE
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email